These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6221689)
1. Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo. Rylander M; Norrby SR Antimicrob Agents Chemother; 1983 Mar; 23(3):352-5. PubMed ID: 6221689 [TBL] [Abstract][Full Text] [Related]
2. Studies on some variables influencing aminoglycoside efficacy in vivo and in vitro. Rylander M; Brorson JE; Holm SE; Norrby R Scand J Infect Dis; 1981; 13(3):217-25. PubMed ID: 6797055 [TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473 [TBL] [Abstract][Full Text] [Related]
4. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens. Digranes A; Dibb WL; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice. Fromtling RA; Abruzzo GK; Gadebusch HH Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance. Corigliano BE; Appleman MD; Heseltine PN; Leedom JM Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085 [TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin. Wise R; Lockley R; Webberly M; Adhami ZN J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932 [TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo activity of ciprofloxacin. Zeiler HJ; Grohe K Eur J Clin Microbiol; 1984 Aug; 3(4):339-43. PubMed ID: 6237902 [TBL] [Abstract][Full Text] [Related]
9. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance. Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248 [TBL] [Abstract][Full Text] [Related]